Mumps Virus Antibodies, IgG and IgM, Spinal Fluid
Use
This test aids in the diagnosis of central nervous system infection caused by the mumps virus. Detection of organism-specific antibodies in cerebrospinal fluid (CSF) may suggest central nervous system infections, although results cannot distinguish between intrathecal antibodies and serum antibodies in the CSF from procedural introduction or blood-brain barrier disruption.
Special Instructions
Not provided.
Limitations
While the presence of antibodies can indicate infection, it should not be the sole criterion for diagnosis. Results must be analyzed within the context of other clinical and laboratory data. The test cannot differentiate between antibodies produced in the central nervous system and those entering through injury to the blood-brain barrier or lumbar puncture procedure.
Methodology
Immunoassay (Immunofluorescence)
Biomarkers
Mumps Virus Antibodies
ProteinMumps Virus Antibodies
Protein
LOINC Codes
- 88458-5 - Mumps virus Ab.IgG & IgM panel CSF IF
- 21401-5 - MuV IgG Titr CSF IF
- 21402-3 - MuV IgM Titr CSF IF
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
0.5 mL
Minimum Volume
0.1 mL
Container
Sterile vial
Collection Instructions
Submit aliquot from collection vial 1.
Causes for Rejection
None specified. Gross hemolysis and lipemia are acceptable.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 14 days |